Cash grants

Open

Supports first-time Turkish technology firms through TÜBİTAK to build startup-ready innovation and commercialization skills.

Open

Funds pilot and feasibility work that prepares a spinal cord injury approach for a future, larger clinical trial.

Open

Funds a spinal cord injury clinical trial that opens with a pre-application stage and calls for named community partners throughout.

Open

Funds spinal cord injury research from basic science through translation, open to investigators at any career stage.

Open

Funds translational spinal cord injury research toward clinical use, with a named community partner and about $2.08 million per award on average.

Open

Funds a clinical trial for service-connected eye injury or visual dysfunction, with a regulatory clock that runs past the application deadline itself.

Open

Funds basic-through-early-translational research on service-connected eye injury or visual dysfunction — clinical trials are not part of this one.

Open

Funds translational work turning a vision-research discovery into a drug, device or guideline ready for a definitive clinical trial.

Open

Connects research teams and institutions for Interregional Innovation Investments Strand in manufacturing, materials science, and agriculture innovation.

Open

Funds EISMEA Interregional Innovation Investments for small and medium-sized enterprises in developing European regions through cross-border transfer and capability building.

Open

Funds a UK trial on the benefits and harms of reconstructive surgery for FGM/C survivors.

Open

Pays Dutch SME representative bodies to make their members' employee commuting greener.

Open

Funds Australian solar PV manufacturing studies and early design validation.

Open

Co-funds R&D projects between a Turkish customer company and an SME supplier, covering 40% of costs.

Open

Invests research teams and institutions for Klima og energisatsinger i industrien in energy systems, climate technology, and manufacturing.

Open

Funds WARF-disclosed UW Madison inventions through patent and licensing preparation for market-ready transfer.

Open

Co-funded R&D for UK space technologies, applications and services

Open

Funds three years replicating a natural product's effect on its target in people, for teams that have already done the pharmacokinetics work.

Open

Funds three years of pharmacokinetics and target-engagement work on a botanical, probiotic or supplement, then three more if the milestones are met.

Open

Funds the mid-phase study that settles a natural product's dose, formulation or responder group before anyone commits to a multi-site efficacy trial.

Open

Pays tenure-track researchers up to $600,000 to build unproven cancer immunotherapy technology.

Open

Funds mathematics driven by real problems in science and engineering — from one investigator to an interdisciplinary team.

Open

Funds startups and industry teams building mobility, transport, and climate technologies through urban innovation support.

Open

Funds shared research instruments too expensive for an ordinary grant — up to $4 million to buy one or to build one that does not exist yet.